| |
| |
|
| Insider
Information: |
Templeman Blaine |
| Relationship: |
Chief Legal Officer |
| City: |
Berkeley |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
121,916 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,924,187 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
121,916 |
|
|
| Total
Value |
$4,924,187 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Chinook Therapeutics Inc |
KDNY |
Chief Legal Officer |
2020-09-15 |
121,916 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KDNY |
Chinook Therapeutics Inc |
Chief Legal Officer |
• – – |
2020-09-15 |
4 |
S |
$2.39 |
$29,585 |
D/D |
(12,369) |
121,916 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Legal Officer |
• – – |
2020-08-07 |
4 |
S |
$2.55 |
$20,308 |
D/D |
(7,951) |
134,285 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Legal Officer |
• – – |
2020-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
142,236 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Legal Officer |
• – – |
2019-12-12 |
4 |
S |
$1.16 |
$1,470 |
D/D |
(1,264) |
117,736 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Legal Officer |
• – – |
2019-09-13 |
4 |
S |
$1.31 |
$16,817 |
D/D |
(12,878) |
117,000 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Legal Officer |
• – – |
2018-12-12 |
4 |
S |
$2.93 |
$3,639 |
D/D |
(1,241) |
129,878 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Legal Officer |
• – – |
2018-11-20 |
4 |
AS |
$2.91 |
$2,453 |
D/D |
(843) |
131,119 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Legal Officer |
• – – |
2018-09-24 |
4 |
AS |
$5.81 |
$59,613 |
D/D |
(10,262) |
131,119 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Executive VP, General Counsel |
• – – |
2018-09-13 |
4 |
S |
$6.50 |
$39,360 |
D/D |
(6,056) |
141,381 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Executive VP, General Counsel |
• – – |
2018-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
77,500 |
147,437 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Legal Officer |
• – – |
2018-05-17 |
4 |
AS |
$8.15 |
$16,300 |
D/D |
(2,000) |
69,937 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Executive VP, General Counsel |
• – – |
2017-12-18 |
4 |
AS |
$8.25 |
$23,793 |
D/D |
(2,884) |
69,937 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Executive VP, General Counsel |
• – – |
2017-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
13,987 |
72,821 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Executive VP, General Counsel |
• – – |
2017-11-17 |
4 |
AS |
$8.85 |
$2,151 |
D/D |
(243) |
58,834 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Executive VP, General Counsel |
• – – |
2017-09-18 |
4 |
AS |
$11.20 |
$32,301 |
D/D |
(2,884) |
58,834 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Executive VP, General Counsel |
• – – |
2017-09-13 |
4 |
S |
$10.99 |
$39,076 |
D/D |
(3,557) |
61,718 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Executive VP, General Counsel |
• – – |
2017-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
27,975 |
65,275 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Executive VP, General Counsel |
• – – |
2017-05-17 |
4 |
AS |
$9.65 |
$15,903 |
D/D |
(1,648) |
37,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Executive VP, General Counsel |
• – – |
2017-01-11 |
4 |
AS |
$11.95 |
$45,231 |
D/D |
(3,785) |
37,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Executive VP, General Counsel |
• – – |
2016-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
37,300 |
38,880 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Executive VP, General CounselO |
• – – |
2015-09-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,580 |
|
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
